BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4624059)

  • 1. [Determination of beta 1 C-A (complement factor 3) in malignant lymphoma, myeloma, and Waldenström's disease].
    Meier EC; Grob PJ
    Dtsch Med Wochenschr; 1972 Jun; 97(25):967-71. PubMed ID: 4624059
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study by means of P.A.S. of peripheral blood lymphocytes in Waldenstrom's disease and in African trypanosomiasis].
    Moretti G; Veyret V; Broustet A
    Nouv Rev Fr Hematol; 1969; 9(5):741-6. PubMed ID: 4189942
    [No Abstract]   [Full Text] [Related]  

  • 3. [The morpho-functional test of blood lymphocytes in proliferative blood diseases. Case reports].
    D'Arrigo S; Lanza C; Lazzaro C
    Riv Patol Clin Sper; 1968; 9(1):3-18. PubMed ID: 4973516
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolism of blood leukocytes in patients with malignant hemopathies and hematosarcomas during the course of chemotherapy].
    Lille I; Gabay P; Clavel B; Saracino RT; Bourdin JS
    Nouv Rev Fr Hematol; 1969; 9(5):715-21. PubMed ID: 4244273
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of "virus-like" particles in the plasmas of 255 patients with leukemia and related diseases.
    Newell GR; Harris WW; Bowman KO; Boone CW; Anderson NG
    N Engl J Med; 1968 May; 278(22):1185-91. PubMed ID: 4172474
    [No Abstract]   [Full Text] [Related]  

  • 6. Leukaemia and allied disorders. 3. Clinical findings in 200 personal cases.
    Woodliff HJ
    Med J Aust; 1972 Aug; 2(8):408-13. PubMed ID: 4628709
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunological behavior of patients with malignant blood diseases].
    Luca N
    Stud Cercet Med Interna; 1973; 14(5):429-46. PubMed ID: 4202394
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum lactic dehydrogenase activity in myeloproliferative and lymphoproliferative disorders.
    Woodliff HJ; Lynch W
    Med J Aust; 1967 Mar; 1(9):431-2. PubMed ID: 5336861
    [No Abstract]   [Full Text] [Related]  

  • 9. The fibrinolytic enzyme system in haematological malignancy.
    Dawson AA; Ogston D; Douglas AS
    Bibl Anat; 1973; 12():272-8. PubMed ID: 4597632
    [No Abstract]   [Full Text] [Related]  

  • 10. [Acute leukemia syndromes (ALS) appearing during the evolution of hematosarcomas and chronic leukemias (clinical analysis)].
    Mathé G; Tubiana M; Calman F; Schlumberger JR; Berumen L; Choquet C; Cattan A; Schneider M
    Nouv Rev Fr Hematol; 1967; 7(4):543-54. PubMed ID: 4228678
    [No Abstract]   [Full Text] [Related]  

  • 11. [B lymphoproliferative syndrome with characteristics common to chronic lymphatic leukemia, Waldenström disease and plasmacytic leukemia].
    Tosato F; Fossaluzza V; Sala P; Tonutti E
    Minerva Med; 1984 Nov; 75(44):2691-4. PubMed ID: 6440066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The primary proliferative processes of the hemopoietic system].
    Introzzi P
    Minerva Med; 1969 Sep; 60(74):3399-450. PubMed ID: 4981171
    [No Abstract]   [Full Text] [Related]  

  • 13. Appropriateness of applying the response criteria for multiple myeloma to Waldenstrom's macroglobulinemia?
    Bladé J; Montoto S; Rosiñol L; Montserrat E
    Semin Oncol; 2003 Apr; 30(2):329-31. PubMed ID: 12720163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytological examination of the lymph nodes in lympho-proliferative diseases].
    VISCA U; FORNI A
    Recenti Prog Med; 1962 Dec; 33():507-68. PubMed ID: 13997474
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of human serum thymic factor on immature T lymphocytes in acute leukemia and other hematologic malignancies.
    Cavdar AO; Ozger Topuz U; Erten J; Losio M; Erten M; Astaldi G
    Isr J Med Sci; 1978 Dec; 14(12):1216-20. PubMed ID: 107146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies on complement system in multiple myeloma and Waldenström's macroglobulinemia--specific patterns and their clinical significance (author's transl)].
    Kuribayashi K
    Rinsho Ketsueki; 1979 Oct; 20(10):1306-13. PubMed ID: 120451
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection and diagnosis of monoclonal gammopathy.
    Sleeper CA; Cawley LP
    Am J Clin Pathol; 1969 Mar; 51(3):395-400. PubMed ID: 4179489
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity of fibrin stabilizing factor (FSF; factor XIII) in lymphoproliferative disorders].
    Kłoczko J; Zuch A; Bielawiec M; Buluk K
    Acta Haematol Pol; 1983; 14(1):13-9. PubMed ID: 6577768
    [No Abstract]   [Full Text] [Related]  

  • 19. Polyacrylamide electrophoresis. II. Study of serum proteins in multiple myeloma and Waldenstrom's macroglobulinemia.
    Dammacco F; Pinto L
    Riv Ist Sieroter Ital; 1967; 42(1):17-23. PubMed ID: 4970260
    [No Abstract]   [Full Text] [Related]  

  • 20. [The blood coagulation system in patients with Waldenstrom's macroglobulinemia and multiple myeloma].
    Kokeva RA; Zhuravlev VS
    Probl Gematol Pereliv Krovi; 1968 Jun; 13(6):10-5. PubMed ID: 4981865
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.